These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 16322846
1. [Ocular toxicity caused by tamoxifen: case report]. Inada ET, Watanabe KP, Tanaka SG, Sakakisbara LA. Arq Bras Oftalmol; 2005; 68(4):554-6. PubMed ID: 16322846 [Abstract] [Full Text] [Related]
5. Crystalline maculopathy: a rare complication of tamoxifen therapy. Srikantia N, Mukesh S, Krishnaswamy M. J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261 [Abstract] [Full Text] [Related]
9. The optical imaging and clinical features of tamoxifen associated macular hole: A case report and review of the literatures. Hu Y, Liu N, Chen Y. Photodiagnosis Photodyn Ther; 2017 Mar; 17():35-38. PubMed ID: 27746263 [Abstract] [Full Text] [Related]
16. Ocular toxicity in low-dose tamoxifen: a prospective study. Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A, Khalil A. Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134 [Abstract] [Full Text] [Related]
17. Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy? Tsai DC, Chen SJ, Chiou SH, Lee AF, Lee FL, Hsu WM. Eye (Lond); 2003 Mar; 17(2):276-8. PubMed ID: 12640432 [No Abstract] [Full Text] [Related]
18. Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia. Wolf-Schnurrbusch UEK, Leung I, Sallo FB, Clemons TE, Chew EY, Bird AC, Peto T, MacTel Study Group. Ophthalmic Res; 2018 Mar; 60(1):38-42. PubMed ID: 28903123 [Abstract] [Full Text] [Related]